Volver a Agenda
Session Chair(s)
Arpad Simon, MD
VP Drug Safety and Pharmcovigilance
Relypsa, United States
Learning Objective : Discuss vaccine pharmacovigilance; Explain pharmacovigilance in special situations such as stem cells and combination products; Identify challenges of disproportionally- based signal detection methodologies in special situations.
Speaker(s)
Safety and Stem Cells
Arpad Simon, MD
Relypsa, United States
VP Drug Safety and Pharmcovigilance
Requirements, Potential Approaches, and Challenges in Pharmacovigilance and Risk Management Practices for Combination Products
Ajay Keshava, MS
WCI Consulting, United States
Managing Consultant
¿Tiene una cuenta?